XML 13 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Revenue $ 2,971,000 $ 2,607,000
Costs and expenses:    
Patient expenses 1,195,000 692,000
Selling, general and administrative 1,232,000 1,179,000
Total 2,427,000 1,871,000
Operating income 544,000 736,000
Interest expense (181,000) (184,000)
Gain from sales of investments in unconsolidated entities 0 237,000
Income from investments in unconsolidated entities 285,000 14,000
Income before income taxes 648,000 803,000
Provision for income tax expense (252,000) (242,000)
Net income $ 396,000 $ 561,000
Basic and diluted net income per share (in dollars per share) $ 0.05 $ 0.07
Weighted average common shares outstanding (in shares) 7,797,185 7,797,185